BioNexus Gene Lab Corp. Due to Affiliate, Current
BioNexus Gene Lab Corp. (BGLC) had Due to Affiliate, Current of $2.11 million as of 2021-03-31, per its 10-Q filed 2021-05-18.
Discontinued › Notes
us-gaap:DueToAffiliateCurrent · last filed 2021-05-18
- 2021-03-31: Due to Affiliate, Current $2.11M.
- 2020-12-31: Due to Affiliate, Current $1.94M.
| Period end | Due to Affiliate, Current |
|---|---|
| 2021-03-31 | $2.11M 10-Q · filed 2021-05-18 |
| 2020-12-31 | $1.94M 10-Q · filed 2021-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |